Patient-derived triple negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics
Sonam Bhatia(Dana-Farber Cancer Institute), David L. Spector(Cold Spring Harbor Laboratory), Suzanne Russo(Case Western Reserve University), Arvind Rishi(Northwell Health), John E. Wilkinson, Taehoon Ha(Cold Spring Harbor Laboratory), Jonathan Preall(Cold Spring Harbor Laboratory), Gayatri Arun(Long Island University), Charles M. Perou(University of North Carolina at Chapel Hill), Dennis Plenker(Cold Spring Harbor Laboratory), W. Richard McCombie(Cold Spring Harbor Laboratory), David A. Tuveson(Cold Spring Harbor Laboratory), Melissa Kramer(Cold Spring Harbor Laboratory), Karen Kostroff(Northwell Health), Cheng Fan(University of North Carolina at Chapel Hill), Peter Andrews(Cold Spring Harbor Laboratory), Payal Naik(Cold Spring Harbor Laboratory), Kyle Brophy(Cold Spring Harbor Laboratory)
Cited by 8
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k